We are live on ! Find out more
LXRX icon

Lexicon Pharmaceuticals
LXRX

145 hedge funds and large institutions have $1.53B invested in Lexicon Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 50 increasing their positions, 38 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

219% more call options, than puts

Call options by funds: $7.88M | Put options by funds: $2.47M

106.32% more ownership

Funds ownership: 0% → 106.32% (+106%)

35% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 20

32% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 38

2% more funds holding

Funds holding: 142 → 145 (+3)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

23% less capital invested

Capital invested by funds: $2B → $1.53B (-$468M)

Holders
145
Holders Change
+3
Holders Change %
+2.11%
% of All Funds
3.63%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
27
Increased
50
Reduced
38
Closed
20
Calls
$7.88M
Puts
$2.47M
Net Calls
+$5.41M
Net Calls Change
-$8.08M

Top Buyers

1
EAM
Eagle Asset Management
Florida
+$18.3M
2
BFA
BlackRock Fund Advisors
California
+$8.16M
3
KCM
Kingdon Capital Management
New York
+$6.54M
4
State Street
State Street
Massachusetts
+$3.74M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$2.72M

Top Sellers

1
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$17.1M
2
UBS AM
UBS AM
Illinois
-$10.8M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$9.29M
4
BM
Bridger Management
New York
-$6.09M
5
Two Sigma Investments
Two Sigma Investments
New York
-$5.13M
Name Holding Trade Value Shares
Change 		Change in
Stake
NFA
51
Nationwide Fund Advisors
Ohio
$1.02M -$59.4K -3,701 -5%
Stifel Financial
52
Stifel Financial
Missouri
$1.01M +$56.1K +3,497 +5%
CS
53
Credit Suisse
Switzerland
$1M +$162K +10,106 +16%
AR
54
Advisory Research
Illinois
$992K +$1.15M +71,692 New
SM
55
Sabby Management
Florida
$969K +$1.12M +70,040 New
Two Sigma Advisers
56
Two Sigma Advisers
New York
$951K -$1.46M -90,750 -57%
Macquarie Group
57
Macquarie Group
Australia
$946K +$201K +12,531 +22%
MAP
58
Moody Aldrich Partners
Massachusetts
$921K +$392K +24,410 +58%
New York State Common Retirement Fund
59
New York State Common Retirement Fund
New York
$861K – – –
PP
60
Paloma Partners
Connecticut
$798K +$926K +57,705 New
BG
61
BlackRock Group
United Kingdom
$769K +$79.1K +4,927 +10%
PAMU
62
Pictet Asset Management (UK)
United Kingdom
$757K +$878K +54,750 New
SO
63
STRS Ohio
Ohio
$697K +$116K +7,200 +17%
PI
64
Putnam Investments
Massachusetts
$656K +$761K +47,407 New
RhumbLine Advisers
65
RhumbLine Advisers
Massachusetts
$640K +$57.2K +3,568 +8%
VRS
66
Virginia Retirement Systems
Virginia
$553K – – –
DCM
67
Driehaus Capital Management
Illinois
$552K -$2.32M -144,369 -78%
SG Americas Securities
68
SG Americas Securities
New York
$543K +$630K +39,255 New
Northwestern Mutual Wealth Management
69
Northwestern Mutual Wealth Management
Wisconsin
$543K +$630K +39,288 New
VKH
70
Virtu KCG Holdings
New York
$523K +$273K +17,022 +82%
Capital Fund Management (CFM)
71
Capital Fund Management (CFM)
France
$520K +$603K +37,593 New
UOTTAIMCU
72
University of Texas/Texas AM Investment Management Co (UTIMCO)
Texas
$494K – – –
SIM
73
Spark Investment Management
New York
$484K +$562K +35,020 New
PCM
74
Piermont Capital Management
Missouri
$482K -$10.8K -670 -2%
ARTA
75
A.R.T. Advisors
New York
$475K +$552K +34,400 New
1 2
3
4 5

LXRX Hedge Fund Activity: Q4 2016 in Review

145 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Lexicon Pharmaceuticals (LXRX) for Q4 2016, worth a combined $1.53B — down 23% from $2B a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new LXRX positions and 20 closed out — a net gain of 7 holders — while 50 added to existing stakes and 38 trimmed.

The largest buyer was Eagle Asset Management, adding an estimated $18.3M. The largest seller was Arrowstreet Capital, exiting entirely with an estimated $17.1M sold.

  • 145 institutional investors held Lexicon Pharmaceuticals (LXRX) as of Q4 2016, up from 142 in Q3 2016.
  • Funds reported $1.53B of Lexicon Pharmaceuticals stock for Q4 2016, down 23% quarter-over-quarter.
  • 27 funds opened new Lexicon Pharmaceuticals positions in Q4 2016 and 20 closed out, a net change of +7 holders.
  • The largest Lexicon Pharmaceuticals buyer in Q4 2016 was Eagle Asset Management, an estimated $18.3M added.
  • The largest Lexicon Pharmaceuticals seller in Q4 2016 was Arrowstreet Capital, an estimated $17.1M sold.

Based on aggregated 13F filings for Q4 2016.